Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pneumococcal Vaccines market report explains the definition, types, applications, major countries, and major players of the Pneumococcal Vaccines market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Valneva Austria
Panacea Biotec
AstraZeneca
Celgene Corporation
Beijing Minhai Biotechnology
ImmunoBiology
Sanofi
Serum Institute of India
Biken
Lupin
Merck
Eli Lilly
GSK
Genentech
Baxter
Sinovac
Nuron Biotech
S K Chemicals
Pfizer
Genocea Biosciences
Biogen
Abera
By Type:
PPSV 23
PCV 7/13
PCV 10
By End-User:
For Infants
For Children (2-10)
For Person (10-64)
For The Old (≥65)
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pneumococcal Vaccines Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pneumococcal Vaccines Outlook to 2028- Original Forecasts
-
2.2 Pneumococcal Vaccines Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pneumococcal Vaccines Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pneumococcal Vaccines Market- Recent Developments
-
6.1 Pneumococcal Vaccines Market News and Developments
-
6.2 Pneumococcal Vaccines Market Deals Landscape
7 Pneumococcal Vaccines Raw Materials and Cost Structure Analysis
-
7.1 Pneumococcal Vaccines Key Raw Materials
-
7.2 Pneumococcal Vaccines Price Trend of Key Raw Materials
-
7.3 Pneumococcal Vaccines Key Suppliers of Raw Materials
-
7.4 Pneumococcal Vaccines Market Concentration Rate of Raw Materials
-
7.5 Pneumococcal Vaccines Cost Structure Analysis
-
7.5.1 Pneumococcal Vaccines Raw Materials Analysis
-
7.5.2 Pneumococcal Vaccines Labor Cost Analysis
-
7.5.3 Pneumococcal Vaccines Manufacturing Expenses Analysis
8 Global Pneumococcal Vaccines Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pneumococcal Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pneumococcal Vaccines Export by Region (Top 10 Countries) (2017-2028)
9 Global Pneumococcal Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Pneumococcal Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global PPSV 23 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PCV 7/13 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global PCV 10 Consumption and Growth Rate (2017-2022)
-
9.2 Global Pneumococcal Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global For Infants Consumption and Growth Rate (2017-2022)
-
9.2.2 Global For Children (2-10) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global For Person (10-64) Consumption and Growth Rate (2017-2022)
-
9.2.4 Global For The Old (≥65) Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pneumococcal Vaccines Market Analysis and Outlook till 2022
-
10.1 Global Pneumococcal Vaccines Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pneumococcal Vaccines Consumption (2017-2022)
-
10.2.2 Canada Pneumococcal Vaccines Consumption (2017-2022)
-
10.2.3 Mexico Pneumococcal Vaccines Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.2 UK Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.3 Spain Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.4 Belgium Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.5 France Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.6 Italy Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.7 Denmark Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.8 Finland Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.9 Norway Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.10 Sweden Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.11 Poland Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.12 Russia Pneumococcal Vaccines Consumption (2017-2022)
-
10.3.13 Turkey Pneumococcal Vaccines Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.2 Japan Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.3 India Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.4 South Korea Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.5 Pakistan Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.6 Bangladesh Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.7 Indonesia Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.8 Thailand Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.9 Singapore Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.10 Malaysia Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.11 Philippines Pneumococcal Vaccines Consumption (2017-2022)
-
10.4.12 Vietnam Pneumococcal Vaccines Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pneumococcal Vaccines Consumption (2017-2022)
-
10.5.2 Colombia Pneumococcal Vaccines Consumption (2017-2022)
-
10.5.3 Chile Pneumococcal Vaccines Consumption (2017-2022)
-
10.5.4 Argentina Pneumococcal Vaccines Consumption (2017-2022)
-
10.5.5 Venezuela Pneumococcal Vaccines Consumption (2017-2022)
-
10.5.6 Peru Pneumococcal Vaccines Consumption (2017-2022)
-
10.5.7 Puerto Rico Pneumococcal Vaccines Consumption (2017-2022)
-
10.5.8 Ecuador Pneumococcal Vaccines Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pneumococcal Vaccines Consumption (2017-2022)
-
10.6.2 Kuwait Pneumococcal Vaccines Consumption (2017-2022)
-
10.6.3 Oman Pneumococcal Vaccines Consumption (2017-2022)
-
10.6.4 Qatar Pneumococcal Vaccines Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pneumococcal Vaccines Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pneumococcal Vaccines Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pneumococcal Vaccines Consumption (2017-2022)
-
10.7.2 South Africa Pneumococcal Vaccines Consumption (2017-2022)
-
10.7.3 Egypt Pneumococcal Vaccines Consumption (2017-2022)
-
10.7.4 Algeria Pneumococcal Vaccines Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pneumococcal Vaccines Consumption (2017-2022)
-
10.8.2 New Zealand Pneumococcal Vaccines Consumption (2017-2022)
11 Global Pneumococcal Vaccines Competitive Analysis
-
11.1 Valneva Austria
-
11.1.1 Valneva Austria Company Details
-
11.1.2 Valneva Austria Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Valneva Austria Pneumococcal Vaccines Main Business and Markets Served
-
11.1.4 Valneva Austria Pneumococcal Vaccines Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Panacea Biotec
-
11.2.1 Panacea Biotec Company Details
-
11.2.2 Panacea Biotec Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Panacea Biotec Pneumococcal Vaccines Main Business and Markets Served
-
11.2.4 Panacea Biotec Pneumococcal Vaccines Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 AstraZeneca
-
11.3.1 AstraZeneca Company Details
-
11.3.2 AstraZeneca Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 AstraZeneca Pneumococcal Vaccines Main Business and Markets Served
-
11.3.4 AstraZeneca Pneumococcal Vaccines Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Celgene Corporation
-
11.4.1 Celgene Corporation Company Details
-
11.4.2 Celgene Corporation Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Celgene Corporation Pneumococcal Vaccines Main Business and Markets Served
-
11.4.4 Celgene Corporation Pneumococcal Vaccines Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Beijing Minhai Biotechnology
-
11.5.1 Beijing Minhai Biotechnology Company Details
-
11.5.2 Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Beijing Minhai Biotechnology Pneumococcal Vaccines Main Business and Markets Served
-
11.5.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 ImmunoBiology
-
11.6.1 ImmunoBiology Company Details
-
11.6.2 ImmunoBiology Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 ImmunoBiology Pneumococcal Vaccines Main Business and Markets Served
-
11.6.4 ImmunoBiology Pneumococcal Vaccines Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Sanofi
-
11.7.1 Sanofi Company Details
-
11.7.2 Sanofi Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Sanofi Pneumococcal Vaccines Main Business and Markets Served
-
11.7.4 Sanofi Pneumococcal Vaccines Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Serum Institute of India
-
11.8.1 Serum Institute of India Company Details
-
11.8.2 Serum Institute of India Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Serum Institute of India Pneumococcal Vaccines Main Business and Markets Served
-
11.8.4 Serum Institute of India Pneumococcal Vaccines Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Biken
-
11.9.1 Biken Company Details
-
11.9.2 Biken Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Biken Pneumococcal Vaccines Main Business and Markets Served
-
11.9.4 Biken Pneumococcal Vaccines Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Lupin
-
11.10.1 Lupin Company Details
-
11.10.2 Lupin Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Lupin Pneumococcal Vaccines Main Business and Markets Served
-
11.10.4 Lupin Pneumococcal Vaccines Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Merck
-
11.11.1 Merck Company Details
-
11.11.2 Merck Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Merck Pneumococcal Vaccines Main Business and Markets Served
-
11.11.4 Merck Pneumococcal Vaccines Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Eli Lilly
-
11.12.1 Eli Lilly Company Details
-
11.12.2 Eli Lilly Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Eli Lilly Pneumococcal Vaccines Main Business and Markets Served
-
11.12.4 Eli Lilly Pneumococcal Vaccines Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 GSK
-
11.13.1 GSK Company Details
-
11.13.2 GSK Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 GSK Pneumococcal Vaccines Main Business and Markets Served
-
11.13.4 GSK Pneumococcal Vaccines Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Genentech
-
11.14.1 Genentech Company Details
-
11.14.2 Genentech Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Genentech Pneumococcal Vaccines Main Business and Markets Served
-
11.14.4 Genentech Pneumococcal Vaccines Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Baxter
-
11.15.1 Baxter Company Details
-
11.15.2 Baxter Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Baxter Pneumococcal Vaccines Main Business and Markets Served
-
11.15.4 Baxter Pneumococcal Vaccines Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 Sinovac
-
11.16.1 Sinovac Company Details
-
11.16.2 Sinovac Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 Sinovac Pneumococcal Vaccines Main Business and Markets Served
-
11.16.4 Sinovac Pneumococcal Vaccines Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 Nuron Biotech
-
11.17.1 Nuron Biotech Company Details
-
11.17.2 Nuron Biotech Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 Nuron Biotech Pneumococcal Vaccines Main Business and Markets Served
-
11.17.4 Nuron Biotech Pneumococcal Vaccines Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 S K Chemicals
-
11.18.1 S K Chemicals Company Details
-
11.18.2 S K Chemicals Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 S K Chemicals Pneumococcal Vaccines Main Business and Markets Served
-
11.18.4 S K Chemicals Pneumococcal Vaccines Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 Pfizer
-
11.19.1 Pfizer Company Details
-
11.19.2 Pfizer Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 Pfizer Pneumococcal Vaccines Main Business and Markets Served
-
11.19.4 Pfizer Pneumococcal Vaccines Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Genocea Biosciences
-
11.20.1 Genocea Biosciences Company Details
-
11.20.2 Genocea Biosciences Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Genocea Biosciences Pneumococcal Vaccines Main Business and Markets Served
-
11.20.4 Genocea Biosciences Pneumococcal Vaccines Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Biogen
-
11.21.1 Biogen Company Details
-
11.21.2 Biogen Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Biogen Pneumococcal Vaccines Main Business and Markets Served
-
11.21.4 Biogen Pneumococcal Vaccines Product Portfolio
-
11.21.5 Recent Research and Development Strategies
-
11.22 Abera
-
11.22.1 Abera Company Details
-
11.22.2 Abera Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
11.22.3 Abera Pneumococcal Vaccines Main Business and Markets Served
-
11.22.4 Abera Pneumococcal Vaccines Product Portfolio
-
11.22.5 Recent Research and Development Strategies
12 Global Pneumococcal Vaccines Market Outlook by Types and Applications to 2028
-
12.1 Global Pneumococcal Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global PPSV 23 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global PCV 7/13 Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global PCV 10 Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pneumococcal Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global For Infants Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global For Children (2-10) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global For Person (10-64) Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global For The Old (≥65) Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pneumococcal Vaccines Market Analysis and Outlook to 2028
-
13.1 Global Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.2.2 Canada Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.2 UK Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.3 Spain Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.5 France Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.6 Italy Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.8 Finland Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.9 Norway Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.11 Poland Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.12 Russia Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.2 Japan Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.3 India Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5.3 Chile Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5.6 Peru Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.6.3 Oman Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pneumococcal Vaccines Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pneumococcal Vaccines Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pneumococcal Vaccines
-
Figure of Pneumococcal Vaccines Picture
-
Table Global Pneumococcal Vaccines Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pneumococcal Vaccines Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global PPSV 23 Consumption and Growth Rate (2017-2022)
-
Figure Global PCV 7/13 Consumption and Growth Rate (2017-2022)
-
Figure Global PCV 10 Consumption and Growth Rate (2017-2022)
-
Figure Global For Infants Consumption and Growth Rate (2017-2022)
-
Figure Global For Children (2-10) Consumption and Growth Rate (2017-2022)
-
Figure Global For Person (10-64) Consumption and Growth Rate (2017-2022)
-
Figure Global For The Old (≥65) Consumption and Growth Rate (2017-2022)
-
Figure Global Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Table North America Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Figure United States Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Canada Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Figure Germany Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure UK Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Spain Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure France Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Italy Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Finland Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Norway Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Poland Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Russia Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table APAC Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Figure China Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table South America Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Figure Brazil Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Chile Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Peru Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table GCC Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Figure Bahrain Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Oman Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table Africa Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Figure Nigeria Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table Oceania Pneumococcal Vaccines Consumption by Country (2017-2022)
-
Figure Australia Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pneumococcal Vaccines Consumption and Growth Rate (2017-2022)
-
Table Valneva Austria Company Details
-
Table Valneva Austria Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valneva Austria Pneumococcal Vaccines Main Business and Markets Served
-
Table Valneva Austria Pneumococcal Vaccines Product Portfolio
-
Table Panacea Biotec Company Details
-
Table Panacea Biotec Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Panacea Biotec Pneumococcal Vaccines Main Business and Markets Served
-
Table Panacea Biotec Pneumococcal Vaccines Product Portfolio
-
Table AstraZeneca Company Details
-
Table AstraZeneca Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Pneumococcal Vaccines Main Business and Markets Served
-
Table AstraZeneca Pneumococcal Vaccines Product Portfolio
-
Table Celgene Corporation Company Details
-
Table Celgene Corporation Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Pneumococcal Vaccines Main Business and Markets Served
-
Table Celgene Corporation Pneumococcal Vaccines Product Portfolio
-
Table Beijing Minhai Biotechnology Company Details
-
Table Beijing Minhai Biotechnology Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Beijing Minhai Biotechnology Pneumococcal Vaccines Main Business and Markets Served
-
Table Beijing Minhai Biotechnology Pneumococcal Vaccines Product Portfolio
-
Table ImmunoBiology Company Details
-
Table ImmunoBiology Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoBiology Pneumococcal Vaccines Main Business and Markets Served
-
Table ImmunoBiology Pneumococcal Vaccines Product Portfolio
-
Table Sanofi Company Details
-
Table Sanofi Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Pneumococcal Vaccines Main Business and Markets Served
-
Table Sanofi Pneumococcal Vaccines Product Portfolio
-
Table Serum Institute of India Company Details
-
Table Serum Institute of India Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Serum Institute of India Pneumococcal Vaccines Main Business and Markets Served
-
Table Serum Institute of India Pneumococcal Vaccines Product Portfolio
-
Table Biken Company Details
-
Table Biken Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biken Pneumococcal Vaccines Main Business and Markets Served
-
Table Biken Pneumococcal Vaccines Product Portfolio
-
Table Lupin Company Details
-
Table Lupin Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Pneumococcal Vaccines Main Business and Markets Served
-
Table Lupin Pneumococcal Vaccines Product Portfolio
-
Table Merck Company Details
-
Table Merck Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Pneumococcal Vaccines Main Business and Markets Served
-
Table Merck Pneumococcal Vaccines Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Pneumococcal Vaccines Main Business and Markets Served
-
Table Eli Lilly Pneumococcal Vaccines Product Portfolio
-
Table GSK Company Details
-
Table GSK Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Pneumococcal Vaccines Main Business and Markets Served
-
Table GSK Pneumococcal Vaccines Product Portfolio
-
Table Genentech Company Details
-
Table Genentech Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Pneumococcal Vaccines Main Business and Markets Served
-
Table Genentech Pneumococcal Vaccines Product Portfolio
-
Table Baxter Company Details
-
Table Baxter Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter Pneumococcal Vaccines Main Business and Markets Served
-
Table Baxter Pneumococcal Vaccines Product Portfolio
-
Table Sinovac Company Details
-
Table Sinovac Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sinovac Pneumococcal Vaccines Main Business and Markets Served
-
Table Sinovac Pneumococcal Vaccines Product Portfolio
-
Table Nuron Biotech Company Details
-
Table Nuron Biotech Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nuron Biotech Pneumococcal Vaccines Main Business and Markets Served
-
Table Nuron Biotech Pneumococcal Vaccines Product Portfolio
-
Table S K Chemicals Company Details
-
Table S K Chemicals Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table S K Chemicals Pneumococcal Vaccines Main Business and Markets Served
-
Table S K Chemicals Pneumococcal Vaccines Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Pneumococcal Vaccines Main Business and Markets Served
-
Table Pfizer Pneumococcal Vaccines Product Portfolio
-
Table Genocea Biosciences Company Details
-
Table Genocea Biosciences Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genocea Biosciences Pneumococcal Vaccines Main Business and Markets Served
-
Table Genocea Biosciences Pneumococcal Vaccines Product Portfolio
-
Table Biogen Company Details
-
Table Biogen Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Pneumococcal Vaccines Main Business and Markets Served
-
Table Biogen Pneumococcal Vaccines Product Portfolio
-
Table Abera Company Details
-
Table Abera Pneumococcal Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abera Pneumococcal Vaccines Main Business and Markets Served
-
Table Abera Pneumococcal Vaccines Product Portfolio
-
Figure Global PPSV 23 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PCV 7/13 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PCV 10 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global For Infants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global For Children (2-10) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global For Person (10-64) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global For The Old (≥65) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Table North America Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Germany Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure China Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pneumococcal Vaccines Consumption Forecast by Country (2022-2028)
-
Figure Australia Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pneumococcal Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
